Regorafenib is a kinase inhibitor. It works in order to inhibit the action of an abnormal protein that signals...
En savoir plusIntroduction: Bortezomib is an anti-cancer drug used for the treatment of patients with multiple myeloma and mantle...
En savoir plusIntroduction: Axitinib falls under the small molecule tyrosine kinase inhibitor. It has been shown to significantly...
En savoir plusThe dual immunotherapy combination of nivolumab and ipilimumab has been approved by the European Commission as...
En savoir plusTrientine is an orally available copper chelating agent, approved for the treatment of Wilson disease, an inherited...
En savoir plusAccording to the announcement by Novartis, outcomes from a couple of pivotal Phase-III international studies demonstrated...
En savoir plusZoledronic acid (Zoledronate) falls under the bisphosphonate family of medications, which acts in order to block...
En savoir plusAccording to study findings, addition of the carfilzomib, a broad-spectrum drug which has low toxicity, along with...
En savoir plusPatients are advised that the cardiac ischemia, infarction and congestive heart failure, have been observed during...
En savoir plusAxitinib is a prescription medicine prescribed for the treatment of advanced kidney cancer (advanced renal cell...
En savoir plus